About
Nordic Biomarker is a Swedish original manufacturer of advanced reagents, calibrators and controls for coagulation analyzers.
Advanced Reagents for Coagulation Analyzers
Nordic Biomarker is a leading European supplier of advanced reagents for coagulation analyzers.
Nordic Biomarker is a Swedish original manufacturer of advanced reagents, calibrators and controls for coagulation and clinical chemistry analyzers and offers products used for a wide range of routine and specialty tests. Our expertise covers all relevant technology areas, and we pride ourselves to being experts when it comes to both immunological, chromogenic as well as clotting assays.
All production is performed in-house at Nordic Biomarker’s facilities in Umeå and Linköping, Sweden. We deliver to OEM-clients around the world for sale under their own brand names as well as to distributors of our portfolio of CE-marked Medirox branded kits. We collaborate closely with our customers to optimize performance on specific instruments and are always happy to provide technical support.
Nordic Biomarker is continuously investing in research and development of new products and will be launching several new assays during the next few years.
With a growing product portfolio of both routine and specialty reagents for the coagulation laboratory, Nordic Biomarker is the ideal collaboration partner for any company seeking to supply the health-care sector with a complete, high quality coagulation/hemostasis reagent package.
Who we are
- Swedish original manufacturer of advanced reagents, calibrators and controls for coagulation and clinical chemistry analyzers
- A supplier with a wide portfolio of products for both routine and specialty tests
- Products are offered both on OEM-basis and as CE-marked kit under the Medirox brand
- Short lead-times and production against orders for maximized shelf-life
- Qualified and fast customer support from highly educated staff
- Continuously on-going research and development and a growing product portfolio
- Collaboration partner for companies seeking a complete hemostasis reagent package
Our history
Medirox merges with Nordic Biomarker creating a leading supplier of reagents, calibrators, and controls for coagulation diagnostics. Our new 2000 sqm custom built, state-of-the-art production facility and clotting center of excellence opens in Linköping. • The vWF:ag immunological assay is launched. • Nordic Biomarker receives the Swedish Government's export award Exporter of the Year 2022.
Our new 5000 sqm custom built, state-of-the-art production facility and Immunologic/Chromogenic center of excellence opens in Umeå. • The Protein C chromogenic assays is launched.
Our patented product MRX PT DOAC, that we believe has the potential to revolutionize that DOAC testing market, is launched as research use only kit.
Nordic Biomarker acquires Medirox. Medirox, a Swedish leading original manufacturer of clotting and chromogenic reagents adding products like PT Quick, PT Owren, APTT, Fib Clauss, Antithrombin and TT to the group’s product offering.
To meet the interest from the Asia market, after several years of research and development a latex reagent for Fibrin(ogen) Degradation Products (FDP) was released.
Nordic Biomarker released the first Free Protein S assay in the world, available on an OEM-basis.
Nordic Biomarker CE-marked the Red and Blue D-dimer kits. In its strive to supply a wider range of specialty reagents for coagulation analyzers, the R&D-project for a Free Protein S Latex Immunoassay was initiated.
To meet the quality expectations from its OEM-partner’s, Nordic Biomarker had worked from the start to comply with applicable standards and regulatory requirements. This work was now awarded with the first ISO 13485 Certification.
Nordic Biomarker released its first product for sale. This was Red D-dimer, which it is still one of the company’s main products. The successful launch of Red D-dimer gave Nordic Biomarker the confidence to move into a 1200 m2 production facility.
Nordic Biomarker was founded by Dr. Gunnar Pohl and Dr. Göran Aronsson. After several years of experience from the IVD-industry, they had realized a market demand for an independent OEM-supplier of high-quality reagents for coagulation analyzers.
Management team
Jonas Wahlqvist
Sales and Marketing Director
Eva Isaksson
CFO
Anna Öberg, M. Sc.
Plant Manager Umeå
Eva Göhl, M. Sc.
Plant Manager Linköping
Malin Walfridsson, Ph. D.
R&D Director
Karin Öhman, M. Sc.
QA/RA Director
Certifications
Nordic Biomarker complies with applicable harmonized standards,
most notably ISO 13485:2016.
ISO 13485:2016
Certification
News
Meet us at CACLP
Exciting News!
We are thrilled to announce that we will be exhibiting at the CACLP Expo 22-24 March . Visit us at booth number 7-E0205 and connect with our team. We look forward to seeing you there!
Read moreNordic Biomarker proudly announces IVDR certification for D-Dimer!
We are excited to share that our D-dimer reagents and their associated calibrators are now officially CE-marked according to IVDR! This is a big milestone for us, as these are our first products to achieve certification under the In Vitro Diagnostic Medical Devices Regulation (IVDR 2017/746). The certification was…
Read moreWinners of the Gnistspridare grant 2024
We are happy to announce this year’s winners of the Gnistspridare grant.
Västerbotten: Exploratoriet Östergötland: Fenomenmagasinet Read moreRead our Supplier Code of Conduct
If you have seen the news about our sustainability report, you may also know that one of our key objectives for 2023 is to establish and implement a supplier code of conduct. And here it is! It is based on our core values and on the Ten Principles of…
Read moreSpecialty Control becomes a multi control
The OEM versions of our Specialty Controls (C3112 and C3113) now include specifications for routine parameters as well. These controls can now be used together with all of the following assays:
Antihrombin APTT D-dimer Fib Clauss Free Protein S Protein C PT Owren PT Quick Thrombin Time vWF Antigen… Read moreNordic Biomarker Acquires Nordic Haemostasis and Expands Control Portfolio
We are proud and happy to announce that we are now able to offer you controls not only for laboratory environment, but also for point-of-care (POC) use.
Nordic Biomarker has acquired Nordic Haemostasis, a company based in Linköping, Sweden, that focuses on POC controls for coagulation diagnostics. Their main clients…
Read moreNordic Biomarker named Exporter of the Year 2022
Image credit: Frida Drake/Regeringskansliet
Nordic Biomarker was awarded the Swedish Government’s prize Exporter of the Year 2022 at a ceremony at the Ministry of Foreign Affairs.
”I am so happy, proud and thankful that what we are achieving together at Nordic Biomarker gets this recognition. All of…
Read moreNordic Biomarker is a Finalist for the Swedish Government’s Export Award
Nordic Biomarker has officially been announced as one of three finalists for the Swedish Government’s award “Export Success of the Year” (Årets exportsuccé).
Press release from Business Sweden (in Swedish)
Press release from the Ministry for Foreign Affairs (in Swedish)
We are very flattered and…
Read moreExpanded intended use for D-dimer
Experience from the pandemic has shown D-dimer to be a prognostic marker for mortality in Covid-19 patients, as well as an aid in managing anticoagulant treatment in this group.
With support in scientific publications, we have now included this as an intended purpose for our D-dimer reagents. Accordingly, our D-dimer…
Read more